No Picture

CSL Opens New, State-of-the-Art Vaccine Research and Development Facility in Waltham, Massachusetts

The site will support CSL’s growing R&D portfolio, accelerating the development of next-generation mRNA technology for vaccines WALTHAM, Mass., March 27, 2023 /PRNewswire/ — Global biotechnology leader CSL (ASX: CSL; USOTC:CSLLY) today celebrated the official opening of the company’s new… Click here to view original post… […]